Molecular response after obinutuzumab plus high-dose cytarabine induction for transplant-eligible patients with untreated mantle cell lymphoma (LyMa-101): a phase 2 trial of the LYSA group
Titel:
Molecular response after obinutuzumab plus high-dose cytarabine induction for transplant-eligible patients with untreated mantle cell lymphoma (LyMa-101): a phase 2 trial of the LYSA group
Auteur:
Le Gouill, Steven Beldi-Ferchiou, Asma Alcantara, Marion Cacheux, Victoria Safar, Violaine Burroni, Barbara Guidez, Stéphanie Gastinne, Thomas Canioni, Danielle Thieblemont, Catherine Maisonneuve, Hervé Bodet-Milin, Caroline Houot, Roch Oberic, Lucie Bouabdallah, Krimo Bescond, Charles Damaj, Ghandi Jaccard, Arnaud Daguindau, Nicolas Moreau, Anne Tilly, Hervé Ribrag, Vincent Delfau-Larue, Marie-Hélène Hermine, Olivier Macintyre, Elizabeth